International Perspectives on Model-Informed Precision Dosing: From the Data to the Patients скачать в хорошем качестве

International Perspectives on Model-Informed Precision Dosing: From the Data to the Patients

1:58 Introduction by Amparo 3:38 Ron Keizer: Continous learning from REal World Data in Model-Informed Precision Dosing 27:15 Sophie Stocker: Implementation of Model-Informed Precision Dosing Into Routine Clinical Practice 48:02 Sebastian Wicha: Model-Informed Precision Dosing of Anti-infectives: Challenges and Potential Solutions 1:10:18 Erwin Dreesen: Model-Informed Precision Dosing of Monoclonal Antibodies in Patients with Immune-mediated Inflammatory Diseases 1:31:47 Manuel Ibarra: Key Aspects for Implementing Model- Informed Precision Dosing in Advancing Therapeutic Drug Monitoring Identifying the right dose of the right drug for the right patient is a central objective of pharmaceutical drug development. However, the ultimate goal of pharmacometrics goes beyond regulatory approvals and commercial successes—it is to be of service to the patient by improving clinical outcomes. Precision dosing goes beyond traditional methods, in that it tailors the best individual dosing regimen for a given patient based on a wide range of factors that may affect the pharmacokinetics and/or response of a drug. Diverse software tools for model-informed precision dosing (MIPD) have been developed for this purpose. In this video, renowned academic and industry scientists from across the globe will share the latest advances in applying MIPD, as well as their insights about how to implement, apply and evolve model-informed precision dosing practices. Learn how other scientists are… • Utilizing continuous learning from real-world data in MIPD • Implementing MIPD in routine clinical practice • Using MIPD for anti-infectives • Leveraging MIPD for administration of monoclonal antibodies in patients with immune-mediated inflammatory diseases • Advancing therapeutic drug monitoring through the implementation of MIPD Our panel of experts includes: • Ron Keizer, Co-founder and Chief Scientist, InsightRX • Sophie Stocker, Senior Lecturer, The University of Sydney • Sebastian Wicha, Professor of Clinical Pharmacy, University of Hamburg • Erwin Dreesen, Assistant Professor of Pharmacometrics, KU Leuven • Manuel Ibarra, Professor, Universidad de la República, Uruguay Our moderators will be: • Amparo de la Peña, Vice President, Pharmacometric Services, Simulations Plus • Ana Ruiz, Gilead Sciences For more information visit: www.simulations-plus.com